chronic lower back pain epidemiology forecast insight

DelveInsight’s ‘Chronic Lower Back Pain (CLBP)—Epidemiology Forecast–2034’ report delivers an in-depth understanding of the CLBP, historical and forecasted epidemiology as well as the CLBP trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Geographies Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Chronic Lower Back Pain (CLBP) Disease Understanding

Chronic low back pain (CLBP) is pain that persists for 12 weeks or longer, even after an initial injury or underlying cause of acute low back pain. Low back pain is widespread and likely to affect everyone at one point. The exact cause of lower back pain is not found yet. Lower back pain that is long-term (for more than 3 months) is called CLBP. This condition might originate from an injury, disease, or stress on different body structures. The pain may vary significantly and be felt as bone pain, nerve pain, or muscle pain, and its intensity ranges from mild to severe. CLBP is the second leading cause of disability worldwide, being a major welfare and economic problem. The prevalence of CLBP in adults has increased significantly in the last decade and is continuously increasing vividly in the aging population. This condition affects men and women in all ethnic groups equally. This disease also leads to stress, depression, and anxiety. CLBP has adverse physical and psychological repercussions. It creates a significant economic burden due to loss of function, loss of work productivity, treatment costs, and disability payments.

Continued in the report…..

Chronic Lower Back Pain Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by total prevalent population of CLBP, total diagnosed prevalent population of CLBP, gender-specific diagnosed prevalence of CLBP, and age-specific diagnosed prevalence of CLBP scenario in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2021 to 2034.

CLBP Detailed Epidemiology Segmentation

• In 2020, the total prevalent population of chronic lower back pain were found out to be 76,440,725 in the 7MM, these cases are expected to grow at a CAGR of 0.54% for the study period 2018–2020.
• The estimates suggest the highest diagnosed prevalent cases of CLBP in the United States with 31,553,732 cases in 2020.
• The total number of CLBP cases in females was 17,291,445 and in males, it was 14,262,287 cases in 2020, in the US.
• The highest number of CLBP cases were in the age group 70+ years with 6,736,354 cases in the EU-5 and the least number of cases of CLBP were found in 18–29 years age group with 2,363,980 cases in 2020, in EU-5.
• Japan had 10,826,931 diagnosed prevalent cases of CLBP in 2020.

Scope of the Report

• The report covers the descriptive overview of CLBP, explaining its causes, symptoms, pathophysiology, and genetic basis.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of chronic lower back pain.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM by total prevalent population of CLBP, total diagnosed prevalent population of CLBP, gender-specific diagnosed prevalence of CLBP, and age-specific diagnosed prevalence of CLBP.

Report Highlights

• 10-Year Forecast of CLBP
• 7MM Coverage
• Total Prevalent Population of Chronic Lower Back Pain
• Total Diagnosed Prevalent Population of Chronic Lower Back Pain
• Gender-specific Diagnosed Prevalence of Chronic Lower Back Pain
• Age-specific Diagnosed Prevalence of Chronic Lower Back Pain

Key Questions Answered

• What are the disease risk, and burden of CLBP?
• What is the historical CLBP patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of CLBP at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to CLBP?
• Out of the above-mentioned countries, which country would have the highest prevalent population of CLBP during the forecast period (2025-2034)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2025-2034)?

Reasons to buy

The chronic lower back pain (CLBP) report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the 7MM CLBP epidemiology forecast.
• The CLBP epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The CLBP epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population